You are here

Therapeutic Advances in Musculoskeletal Disease

Therapeutic Advances in Musculoskeletal Disease

Other Titles in:
Arthritis | Gout | Rheumatology

eISSN: 17597218 | ISSN: 1759720X | Current volume: 15 | Current issue: 1 Frequency: Yearly

Journal Highlights

  • Launched in 2009.
  • Gold open access journal – all articles are made freely available online immediately upon publication.
  • Rigorous peer review.
  • Listed in PubMed and indexed in Science Citation Index Expanded (SCIE), Scopus, and ProQuest.
  • A leading gold open access journal in musculoskeletal diseases.
  • Over 300,000 full-text article views annually.
Therapeutic Advances in Musculoskeletal Disease is a peer-reviewed open access journal which focuses on pioneering efforts and innovative studies across all areas of rheumatology, osteoporosis and related disciplines. Please see the aims and scope tab for further information.

This journal is a member of the Committee on Publication Ethics (COPE).

Diversity, Equity and Inclusion Statement

Therapeutic Advances in Musculoskeletal Disease promotes inclusive, open science that reflects the disciplinary, human, and geographic diversity of the musculoskeletal disease community.

Diversity as a core value embodies inclusiveness, mutual respect, and multiple perspectives.

We welcome editors, editorial board members, peer reviewers and authors from all backgrounds, cultures, ethnicities, nationalities, races, religions, sexes, sexual orientations, gender identities, mental or physical (dis)abilities, ages, career stages, socioeconomic status or any other individual status.

We are committed to continually improving our editorial and review processes whilst playing our part in eradicating bias and inequality in all forms.

Submission information

Submit your manuscript today at http://mc.manuscriptcentral.com/tamd.

Please see the submission guidelines tab for more information on how to submit your article to the journal.

Open access information

Unsolicited manuscripts submitted to Therapeutic Advances in Musculoskeletal Disease are subject to an article processing charge (APC) of 2650 USD.

Articles are published under a Creative Commons licence and will be made openly available.

The APC is payable when a manuscript is accepted after peer review, before it is published. The APC is subject to taxes where applicable. Please see further details here.

Contact

Please direct any queries to alex.baliani@sagepub.co.uk. This journal changed its publication mode from subscription to open access in 2019.

Therapeutic Advances in Musculoskeletal Disease delivers the highest quality peer-reviewed open access original research articles, reviews, and scholarly comment on pioneering efforts and innovative studies in the medical treatment of osteoporosis and rheumatic diseases such as rheumatoid arthritis, osteoarthritis, psoriatic arthritis, ankylosing spondylitis and other related musculoskeletal diseases. The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in rheumatology, osteoporosis and related disciplines, providing an online forum for rapid dissemination of recent research and perspectives in this area.

The journal is dedicated to publishing clinical research. We do not publish preclinical research, including basic laboratory research and animal studies.

Review articles include expert opinion/perspective reviews (including single-drug and drug class reviews), narrative reviews and therapeutic area reviews. Systematic reviews, meta-analyses, postmarketing and health economic and pharmacoeconomic reviews are also welcomed. The appropriate EQUATOR Network reporting guidelines should be follows (e.g. CONSORT for randomized, controlled trials and PRISMA for systematic reviews/meta-analyses). The journal endorses the ICMJE requirement that clinical trials are registered in a WHO-approved public trials registry at or before the time of first patient enrolment. However, consistent with the AllTrials campaign, retrospectively registered trials will be considered if the justification for late registration is acceptable.

The journal adheres to a blind review process in which the reviewer's name is routinely withheld from the author unless the reviewer requests a preference for their identity to be revealed. Manuscripts are reviewed by at least two referees; online publication is usually within 3 weeks of Acceptance.

Editor-in-Chief
Denis Poddubnyy Charité University Hospital, Berlin, Germany
Managing Editor
Jemima Williamson SAGE Publishing, London, UK
Assistant Managing Editor
Pooja Sharma SAGE Publishing, New Delhi, India
Associate Editors
Giovanni Adami University of Verona,Verona, Italy
Mohit Bhandari McMaster University, Ontario, ON, Canada
Christian Dejaco University of Graz, Graz, Austria
Jörg Distler Universitatsklinikum Düsseldorf
Miguel A. González-Gay University of Cantabria, Santander, Spain
Yves Henrotin University of Liège, Liège, Belgium
Charles Malemud Case Western Reserve University School of Medicine, Cleveland, OH, USA
Johanne Martel-Pelletier University of Montreal, Montreal, Canada
Ali Mobasheri University of Oulu, Oulu, Finland
Chi-Chiu Mok Tuen Mun Hospital, Hong Kong, SAR China
Elena Myasoedova Mayo Clinic College of Medicine, Rochester, MN, USA
Tuan V. Nguyen Garvan Institute of Medical Research, Darlinghurst, NSW, Australia
Mary O'Keeffe The University of Sydney, Sydney, Australia
Francisca Sivera Hospital General Universitario Elda, Elda, Alicante, Spain
Biostatistical Editors
Ahmad Abuhelwa Flinders Medical Centre and Flinders University, Bedford Park, Australia
Ram Bajpai School of Medicine, Keele University, UK
Raveendhara Bannuru Tufts Medical Center, Boston, MA, USA
Diederik De Cock Vrije Universiteit Brussel, Brussels, Belgium
Christiana Demetriou University of Nicosia Medical School, Nicosia, Cyprus
Gwo-Ping Jong Chung Shan Medical University, Taichung, Taiwan
Gerardo Quintana Lopez Universidád Nacionál de Colómbia, Bogotá, Colombia
Cinzia Rotondo University of Foggia, Foggia, Italy
Vitaly Schetinin University of Bedfordshire, Luton, UK
Alexandre Sepriano Leiden University Medical Center, Leiden, The Netherlands
Honglin Zhu Xiangya Hospital, Central South University, Changsha, China
Social Media Editor
George Fragoulis Laiko Hospital, Athens, Greece
Diversity, Equity and Inclusion Ambassador
Latika Gupta Royal Wolverhampton Hospital NHS Trust, Wolverhampton, UK
Editorial Board
Shreyasee Amin Mayo Clinic, Rochester, MN, USA
Gerolamo Bianchi La Colletta Hospital, Arenzano, Italy
Milena Bond Brunico Hospital, Brunico, Italy
Chad S. Boomershine Vanderbilt University, Nashville, TN, USA
Mary Bouxsein Beth Israel Deaconess Medical Center, Boston, MA, USA
Juliet E Compston Cambridge University, Cambridge, UK
Nicoletta Del Papa ASST Gaetano Pini-CTO Institute, Milan, Italy
Bohdana Doskaliuk Ivano-Frankivsk National Medical University, Ivano-Frankivsk, Ukraine
Christina Duftner Medical University Innsbruck, Innsbruck, Austria
Piet Geusens University Hospital, Maastricht, Netherlands
Anna-Maria Hoffmann-Vold Oslo University Hospital, Oslo, Norway
Deepak Jadon Cambridge University Hospitals, Cambridge, UK
Dinesh Kumbhare McMaster University, Toronto, ON, Canada
Willem Lems VU University Medical Center, Amsterdam, Netherlands
Ken Lyles Duke University School of Medicine, Durham, NC, USA
Marco Matucci-Cerinic Azienda Ospedaliera Universitaria Careggi, University of Florence, Florence, Italy
Fergus McKiernan Marshfield Clinic, Marshfield, WI, USA
Anna Molto Hôpital Cochin - Groupe Hospitalier Paris Centre, Paris, France
Ran Nakashima Kyoto University, Kyoto , Japan
Maria Victoria Navarro Compán Hospital Universitario La Paz, Madrid, Spain
Terence O'Neill Manchester University, Manchester, UK
Phillipe Orcel University Hospital Lariboisiere, Paris, France
Adolfo Diez Perez Autonomous University of Barcelona, Barcelona, Spain
Jean-Yves Reginster Bone and Cartilage Mebolism Unit, Liege, Belgium
Rene Rizzoli University Hospitals and Faculty of Medicine of Geneva, Geneva, Switzerland
Sebastian Sattui University of Pittsburg, PA, USA
Valentin Schäfer University Hospital Bonn, Bonn, Germany
Stuart Silverman The Osteoporosis Medical Center, Beverly Hills, CA, USA
Jasvinder A. Singh University of Alabama, Birmingham, AL, USA
Yoshiya Tanaka The First Department of Internal Medicine, Kitakyushu, Japan
Bobo Tanner Vanderbilt University, Nashville, TN, USA
Giustino Varrassi Paolo Procacci Foundation, Rome, Italy
Olena Zimba University Hospital in Krakow, Krakow, Poland
Editorial Review Board
Ho SO, MD, MSc The Chinese University of Hong Kong, Hong Kong
Qiang Tong, MD, PhD Shanghai Sixth People's Hospital, Shanghai Jiao Tong University, China
  • Clarivate Analytics: Current Contents - Clinical Medicine
  • Clarivate Analytics: Science Citation Index Expanded (SCIE)
  • Directory of Open Access Journals (DOAJ)
  • ProQuest
  • PubMed Central (PMC)
  • Scopus
  • Manuscript submission guidelines can be accessed on Sage Journals.